April tax data show a smaller market is finally supporting bigger average stores
Oklahoma’s retail cannabis market is still smaller than it was a year ago. But the average dispensary is finally carrying more volume.
State data released by the Oklahoma Medical Marijuana Authority, the agency that licenses the industry and publishes monthly tax tables, show April 2026 medical marijuana excise-tax collections of $3,537,839. That was below April 2025’s $3,907,287. On its face, that is a weak headline. It means the statewide pool of taxable retail sales was still down year over year.
The sharper point sits underneath it. Oklahoma applies a 7% excise tax to retail medical marijuana sales from dispensaries to patients. Backing that tax line into taxable sales implies about $50.5 million in April 2026 retail sales, down from about $55.8 million in April 2025. But the number of active dispensary licenses fell much faster than sales did. OMMA listed 1,361 active dispensaries on May 1, 2026, down from 1,681 a year earlier. Using those counts, implied taxable sales averaged about $37,135 per active dispensary in April 2026, up 11.8% from about $33,205 in April 2025.
That is why this matters now. For years, Oklahoma’s story has been simple: too many licenses chasing too little lawful demand in a medical-only market. The state’s own supply-and-demand study said the regulated market had significant oversupply. Store closures and license attrition were expected. The harder question was whether the washout would ever improve the economics of the operators left standing. These numbers suggest it finally is.
The timing gives the data extra weight. Oklahoma’s moratorium on new dispensary, grower, and processor licenses is scheduled to run until Aug. 1, 2026, unless lawmakers extend it again or OMMA’s process changes its timing around pending reviews, inspections, or investigations. That puts a hard deadline on a debate that had become abstract. The issue is no longer only how many licenses have disappeared. It is whether the remaining base has begun to function better before new entrants are allowed back in.
The market is not growing again in any broad sense. Statewide taxable sales were lower. The point is narrower and more important. Fewer stores are now splitting that market. In a business where rent, payroll, security, software, testing, transport, and compliance all have to be paid before profit appears, that change in throughput can matter more than a general headline about total sales.
The 7% excise tax turns a monthly state table into a productivity signal
This calculation is straightforward, but its meaning is easy to miss without the structure around it.
Under State Question 788, Oklahoma levies a 7% excise tax on retail sales of medical marijuana and medical marijuana products from dispensaries to patients. That means the monthly excise-tax figure is a direct read on the taxable retail base. Divide the April 2026 excise collection of $3,537,839 by 0.07, and the result is roughly $50.5 million in taxable sales. Do the same for April 2025, and the figure is about $55.8 million.
The second step is what changes the story. Divide those statewide sales estimates by the active dispensary count reported by OMMA, and the tax table becomes a rough productivity measure for the average licensed store. It is not a measure of actual revenue at any one location. Some dispensaries are far above that average, some well below it, and some license holders may not be operating at full pace despite being counted as active. But as a statewide signal, it is useful. It shows how much lawful retail volume the existing store base is trying to absorb.
That distinction matters because Oklahoma’s market has spent several years trapped in a false choice between two bad readings. One reading focused only on license counts, which showed contraction but not whether survivors were healthier. The other focused only on total sales or tax collections, which could stay flat or decline even while store-level economics improved. The current data break that stalemate. Total sales are still down, but average throughput per active dispensary is up.
The moratorium is the institutional reason that signal can now be seen. When the state pauses new dispensary, grower, and processor licenses, attrition starts to matter. Stores close, licenses lapse, weaker operators exit, and the surviving network handles more of the legal market by default. In practical terms, the moratorium has acted like a pressure valve on competition at the same time the market has been trying to work through years of oversupply.
That does not mean the policy solved everything. A freeze on new licenses does not create new patient demand. It does not guarantee better pricing, cleaner distribution, or stronger enforcement. It does not turn a medical market into an adult-use market with a much larger consumer base. Oklahoma is still limited by the size and behavior of its registered-patient system, and the state’s own research has already shown that regulated capacity exceeded that demand by a wide margin.
Still, the new average-store figure matters precisely because it comes from that constrained setting. If throughput is improving in a market with no adult-use expansion to rescue it, then the correction is not just cosmetic. It suggests the store base itself is becoming more proportionate to the demand that actually exists.
There is also a mechanical reason current operators will pay attention. Store economics do not improve line by line all at once. They improve when fixed costs are spread across more transactions. A dispensary that moves more volume through the same lease, roughly the same staffing core, and the same compliance overhead has more room to defend margin. It can buy more deliberately, hold inventory with less strain, and operate with less day-to-day fragility. An 11.8% increase in implied taxable sales per active dispensary does not guarantee profitability. It does, however, move the average operator in the right direction.
Retailers benefit first, but the whole medical supply chain feels the shift
The first clear beneficiaries are surviving dispensaries. Oklahoma had 1,361 active dispensary licenses on May 1 out of 4,103 total active business licenses. That is still a large store base for a medical market. But it is materially smaller than it was a year earlier, and that alone changes how each remaining store fits inside local competition.
For retailers, better average throughput means more than higher sales. It affects bargaining power with suppliers, labor scheduling, stock turns, and how much waste the business can carry. A store that moves product faster can refresh menus more often and has less reason to rely on deep discounting just to clear aging inventory. It also has a better chance of meeting the ordinary obligations that make a regulated business durable: rent on time, payroll without delay, taxes without emergency financing, and compliance spending without constant deferral.
That said, the average can hide a lot. Oklahoma is not one market in the street-level sense. It is a statewide regulatory system made up of very different local trade areas. Some towns still have too many stores. Some surviving dispensaries may be carrying far more than the implied average, while others are merely lasting a little longer in a difficult corridor. The new data do not prove that most stores are healthy. They show that the market is no longer diluting retail demand as severely as it did a year ago.
Growers and processors should read the signal differently. The moratorium did not apply only to dispensaries. It also covered new grower and processor licenses, which means upstream capacity has also been held back while the industry contracted. In theory, fewer stores with slightly stronger throughput can create steadier purchasing patterns and somewhat cleaner wholesale relationships. In practice, that adjustment is slower. Oklahoma’s oversupply problem was not only a retail problem. It was also a production problem. A stronger average dispensary does not automatically absorb surplus flower or repair weak wholesale pricing.
For brands and product manufacturers, the improvement is real but selective. A more productive store network can be better for repeat orders and shelf stability. It can also be harsher for weaker brands. When surviving retailers are less desperate, they gain more freedom to concentrate shelf space on products that actually move. That can favor operators with strong local demand and disciplined distribution, while exposing products that survived only because the old market was chaotic.
Landlords, lenders, and private investors also have a clearer read than they did a year ago. Oklahoma cannabis has long been hard to underwrite because a high store count did not tell anyone whether the market was commercially rational. The new figures do not erase the risk, but they do suggest that attrition is starting to improve unit-level productivity. For anyone judging a tenant, a borrower, or a potential acquisition target, that is more useful than a raw count of closures. It suggests the survivors are not just fewer in number. They may be inheriting a larger share of the lawful market.
Would-be entrants face the most awkward position of all. On one hand, the recent correction makes Oklahoma look less irrational than it did during the height of license saturation. On the other hand, the same data say the market is only now beginning to clear. Entering immediately after years of forced rationalization is not the same as entering a growth market. It is entering a medical system where total taxable sales were still lower than a year ago and where the improvement rests largely on fewer operators dividing the same demand.
That is why the August deadline matters beyond administrative process. If the moratorium lapses and a new wave of applicants can enter, the state may start adding capacity at the exact moment the existing market has only begun to restore store-level productivity. If the freeze continues, current operators may get more time for this improvement to compound. Neither outcome is guaranteed to produce a healthy market, but they are not equivalent.
Oklahoma’s correction is finally doing its intended job, but the state can still interrupt it
The cleanest reading of the new data is also the most restrained one. Oklahoma has not fixed its cannabis market. It has begun, finally, to make the surviving retail base more economically coherent.
That is a meaningful shift because the state’s long contraction often looked like destruction without repair. Licenses disappeared. Enforcement and licensing rules tightened. The oversupply study confirmed what operators already knew. Yet none of that automatically proved that the businesses left behind were becoming stronger. April’s tax and license figures do not settle the question for every operator, but they do show the mechanism working. Less store count dilution is translating into more average sales throughput per active dispensary.
That should shape how the next few months are discussed. The key issue is not whether Oklahoma once had too many licenses. The state’s own work has already answered that. The key issue is whether policymakers and the regulator allow the rationalization process to run long enough to produce a market that can support compliance, ordinary business discipline, and legal retail trade without depending on endless churn.
There are still obvious limits to what this one snapshot can prove. The calculation uses statewide tax data and active-license counts, not store-by-store revenue. It compares April sales with a May 1 license denominator, which is close in time but not identical. It captures one month, not a full year. And even with the improvement, total statewide taxable sales were lower than they were a year earlier. None of that should be ignored.
But none of it cancels the central point either. Oklahoma’s medical cannabis market is now producing more implied taxable sales per active dispensary even while the overall retail pie remains smaller. In plain terms, the average licensed store is getting a better shot at being a functioning business.
That makes the upcoming decision on the moratorium more consequential than it may appear on paper. A licensing freeze can look like a technical administrative tool. In Oklahoma, it has become part of the market’s repair sequence. If the state reopens broad entry into dispensaries, grows, and processing too quickly, it risks adding fresh capacity before the current base has fully stabilized. If it holds the line longer, it may give the market time to convert mere survival into durable operating structure.
The evidence now says the washout is starting to produce an economic result, not just a smaller license roster. That is progress. It is also the point at which policy choices start to matter most.